N-PORT filing recap · July 2025
What did Davis New York Venture Fund buy in July 2025?
Reported stock-position changes between this filing and the previous one. These are Davis New York Venture Fund's own holdings, not the firm's.
Stock value
$6.44B
Positions
44
Estimated turnover
12.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Davis New York Venture Fund opened new positions in UnitedHealth Group and Pinterest. It trimmed Meta Platforms, Berkshire Hathaway, Amazon, Alphabet, and Wells Fargo, while substantially reducing Humana, Quest Diagnostics, and Coupang. The fund also substantially added to Tyson Foods and Coterra Energy, and modestly increased US Bancorp.